Van Thiel D H, Dindzans V J, Schade R R, Rabinovitz M, Gavaler J S
Division of Gastroenterology, University of Pittsburgh, School of Medicine, Pennsylvania 15261.
Dig Dis Sci. 1993 Aug;38(8):1505-10. doi: 10.1007/BF01308612.
From January 1985 through July 1987, adult patients accepted for liver transplantation with large esophageal varices were enrolled in a study evaluating the use of prophylactic vs emergency sclerotherapy. Six hundred forty-eight subjects received prophylactic sclerotherapy, and 172 received emergent sclerotherapy. Esophageal stricture formation was increased 12.9-fold (P < 0.001), esophageal perforation 6.4-fold (P < 0.005), and postsclerotherapy bleeding esophageal ulcers 3.7-fold (P < 0.001) in those receiving emergency sclerotherapy as opposed to prophylactic sclerotherapy. These differences were even greater if the number of sclerotherapy sessions rather than the number of patients was used as the denominator for the comparisons. In total, 19.6% of emergency sclerotherapy cases were associated with an untoward outcome of sclerotherapy; only 1.9% of cases receiving prophylactic sclerotherapy experienced an untoward outcome (P < 0.001). These data demonstrate that emergency sclerotherapy is associated with a greater prevalence of complications and support earlier studies that show that sclerotherapy prevents variceal bleeding over the short term. The data also suggest that when applied to patients with large varices awaiting orthotopic liver transplantation, it enhances the chance of a patient surviving to be transplanted by preventing a variceal bleed and the spiral of liver failure and death that frequently follows an episode of acute variceal bleeding.
从1985年1月至1987年7月,因患有大型食管静脉曲张而接受肝移植的成年患者被纳入一项研究,该研究旨在评估预防性硬化疗法与急诊硬化疗法的使用情况。648名受试者接受了预防性硬化疗法,172名接受了急诊硬化疗法。与预防性硬化疗法相比,接受急诊硬化疗法的患者食管狭窄形成增加了12.9倍(P<0.001),食管穿孔增加了6.4倍(P<0.005),硬化治疗后出血性食管溃疡增加了3.7倍(P<0.001)。如果将硬化治疗疗程数而非患者数作为比较的分母,这些差异会更大。总体而言,19.6%的急诊硬化治疗病例与硬化治疗的不良后果相关;接受预防性硬化治疗的病例中只有1.9%出现不良后果(P<0.001)。这些数据表明,急诊硬化疗法与更高的并发症发生率相关,并支持早期研究,这些研究表明硬化疗法可在短期内预防静脉曲张出血。数据还表明,当应用于等待原位肝移植的大型静脉曲张患者时,它通过预防静脉曲张出血以及急性静脉曲张出血发作后常伴随的肝衰竭和死亡螺旋,提高了患者存活至接受移植的机会。